{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:14:23Z","timestamp":1788966863685,"version":"build-2803163510"},"reference-count":58,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T00:00:00Z","timestamp":1570492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2019.01161","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T04:12:51Z","timestamp":1570507971000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":38,"title":["Ototoxic Adverse Drug Reactions: A Disproportionality Analysis Using the Italian Spontaneous Reporting Database"],"prefix":"10.3389","volume":"10","author":[{"given":"Maria Antonietta","family":"Barbieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cicala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola Maria","family":"Cutroneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Mocciaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sottosanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Freni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Galletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Arcoraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Spina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2019,10,8]]},"reference":[{"key":"B1","unstructured":""},{"key":"B2","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1001\/archinte.168.14.1522","article-title":"Prevalence of hearing loss and differences by demographic characteristics among US adults: data from the National Health and Nutrition Examination Survey, 1999\u20132004","volume":"168","author":"Agrawal","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/jso.2930160203","article-title":"Auditory toxicity effects of long-term cis-dichlorodiammineplatinum II therapy in genitourinary cancer patients","volume":"16","author":"Aguilar-Markulis","year":"1981","journal-title":"J. Surg. Oncol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1080\/14992027.2017.1405162","article-title":"Use of beta blockers is associated with hearing loss","volume":"57","author":"Al-Ghamdi","year":"2018","journal-title":"Int. J. Audiol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"727","DOI":"10.5935\/1808-8694.20130133","article-title":"Phosphodiesterase type 5 inhibitors and sudden sensorineural hearing loss","volume":"79","author":"Barreto","year":"2013","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1136\/bmj.39301.680266.AE","article-title":"Ototoxicity caused by aminoglycosides","volume":"335","author":"Bitner-Glindzicz","year":"2007","journal-title":"Br. Med. J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.curtheres.2005.10.001","article-title":"Prevalence of tinnitus in patients with hypertension and the impact of different antihypertensive drugs on the incidence of tinnitus: a prospective, single-blind, observational study","volume":"66","author":"Borghi","year":"2005","journal-title":"Curr. Ther. Res. - Clin. Exp."},{"key":"B8","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1080\/14992027.2017.1355570","article-title":"Ototoxicity monitoring in children treated with platinum chemotherapy","volume":"57","author":"Brooks","year":"2018","journal-title":"Int. J. Audiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"109","DOI":"10.2165\/00002018-199920020-00002","article-title":"The medical dictionary for regulatory activities (MedDRA)","volume":"20","author":"Brown","year":"1999","journal-title":"Drug Saf."},{"key":"B10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0030-6665(20)30768-4","article-title":"Ototoxic liability of erythromycin and analogues","volume":"26","author":"Brummett","year":"1993","journal-title":"Otolaryngol. Clin. North Am."},{"key":"B11","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s40264-017-0629-8","article-title":"Drug-induced ototoxicity: diagnosis and monitoring","volume":"41","author":"Campbell","year":"2018","journal-title":"Drug Saf."},{"key":"B12","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1007\/s11882-013-0416-2","article-title":"Efficacy and safety of long-term antibiotics (macrolides) for the treatment of chronic rhinosinusitis","volume":"14","author":"Cervin","year":"2014","journal-title":"Curr. Allergy Asthma Rep."},{"key":"B13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-0042-1748061","article-title":"Cisplatin ototoxicity, increased DPOAE amplitudes, and magnesium deficiency. Distortion product otoacoustic emissions","volume":"11","author":"Cevette","year":"2000","journal-title":"J. Am. Acad. Audiol."},{"key":"B14","first-page":"601","article-title":"Pharmacological drugs inducing ototoxicity, vestibular symptoms and tinnitus: a reasoned and updated guide","volume":"15","author":"Cianfrone","year":"2011","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"B15","first-page":"14","article-title":"A case report of onset of tinnitus following discontinuation of antidepressant and a review of the literature","volume-title":"Prim. Care Companion CNS Disord.","author":"Clewes","year":"2012"},{"key":"B16","first-page":"273","article-title":"Otoacoustic emissions analysers for monitoring aminoglycosides ototoxicity","volume":"47","author":"Constantinescu","year":"2009","journal-title":"Rom. J. Intern. Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/(SICI)1099-1557(199905\/06)8:3<217::AID-PDS415>3.3.CO;2-H","volume":"8","year":"1999","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1007\/s00405-009-0975-y","article-title":"Subjective audiological tests and transient evoked otoacoustic emissions in patients with rheumatoid arthritis: analysis of the factors affecting hearing levels","volume":"266","author":"Dikici","year":"2009","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1212\/WNL.22.4.323","article-title":"An approach to the dizzy patient","volume":"22","author":"Drachman","year":"1972","journal-title":"Neurology"},{"key":"B20","doi-asserted-by":"publisher","first-page":"453","DOI":"10.2165\/00002018-200225060-00010","article-title":"Use of measures of disproportionality in pharmacovigilance: three Dutch examples","volume":"25","author":"Egberts","year":"2002","journal-title":"Drug Saf."},{"key":"B21","unstructured":""},{"key":"B22","unstructured":""},{"key":"B23","first-page":"1","article-title":"Summary of the risk management plan (RMP) for Pemetrexed Lilly (pemetrexed)","year":"2015"},{"key":"B24","unstructured":"Guideline on good pharmacovigilance practices (GVP) annex I\u2014definitions (rev 4)133Heads Med. Agencies2017"},{"key":"B25","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00232-004-0703-x","article-title":"Localization of \u03b21-adrenergic receptors in the cochlea and the vestibular labyrinth","volume":"201","author":"Fauser","year":"2004","journal-title":"J. Membr. Biol."},{"key":"B26","unstructured":"ULTRAM\u00ae (tramadol hydrochloride) tablets1222003"},{"key":"B27","unstructured":"NAVELBINE (vinorelbine), NDA 0203882014"},{"key":"B28","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1002\/j.1552-4604.1994.tb02042.x","article-title":"Topical ophthalmic beta-adrenergic blockade for the treatment of glaucoma and ocular hypertension","volume":"34","author":"Frishman","year":"1994","journal-title":"J. Clin. Pharmacol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.phrs.2004.08.003","article-title":"Neuropsychiatric reactions to drugs: an analysis of spontaneous reports from general practitioners in Italy","volume":"51","author":"Galatti","year":"2005","journal-title":"Pharmacol. Res."},{"key":"B30","doi-asserted-by":"publisher","first-page":"59","DOI":"10.7874\/jao.2017.00360","article-title":"Ototoxicity: a challenge in diagnosis and treatment","volume":"22","author":"Ganesan","year":"2018","journal-title":"J. Audiol. Otol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/0378-4274(90)90033-I","article-title":"Aminoglycoside-induced ototoxicity","volume":"52","author":"Govaerts","year":"1990","journal-title":"Toxicol. Lett."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.rmed.2006.01.014","article-title":"Side effects due to primary antituberculosis drugs during the initial phase of therapy in 1149 hospitalized patients for tuberculosis","volume":"100","author":"G\u00fclbay","year":"2006","journal-title":"Respir. Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/S0002-9343(99)00260-0","article-title":"Evaluating dizziness","volume":"107","author":"Hoffman","year":"1999","journal-title":"Am. J. Med."},{"key":"B34","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1080\/00016480510038617","article-title":"Estrogen and hearing: a summary of recent investigations","volume":"126","author":"Hultcrantz","year":"2006","journal-title":"Acta Otolaryngol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1288\/00005537-194805000-00002","article-title":"The hearing acuity, tinnitus and vertigo in essential hypertension","volume":"58","author":"Johnson","year":"1948","journal-title":"Laryngoscope"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1136\/annrheumdis-2011-201265","article-title":"Antimalarial ototoxicity: an underdiagnosed complication? A study of spontaneous reports to the French Pharmacovigilance Network","volume":"71","author":"Jourde-Chiche","year":"2012","journal-title":"Ann. Rheum. Dis."},{"key":"B37","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/coa.12242","article-title":"Patients with osteoporosis have higher incidence of sensorineural hearing loss","volume":"39","author":"Kahveci","year":"2014","journal-title":"Clin. Otolaryngol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1002\/cpt.603","article-title":"Drug-induced ototoxicity: mechanisms, pharmacogenetics, and protective strategies","volume":"101","author":"Lanvers-Kaminsky","year":"2017","journal-title":"Clin. Pharmacol. Ther."},{"key":"B39","first-page":"28","article-title":"A three-arm trial of vinorelbine (Navelbine) plus cisplatin, vindesine plus cisplatin, and single-agent vinorelbine in the treatment of non\u2013small cell lung cancer: an expanded analysis","volume":"21","author":"Le Chevalier","year":"1994","journal-title":"Semin. Oncol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s12070-011-0405-5","article-title":"Hearing loss in patients of chronic renal failure: a study of 100 cases","volume":"64","author":"Meena","year":"2012","journal-title":"Indian J. Otolaryngol. Head Neck Surg."},{"key":"B41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijporl.2017.06.037","article-title":"Hearing loss in children with growth hormone deficiency","volume":"100","author":"Muus","year":"2017","journal-title":"Int. J. Pediatr. Otorhinolaryngol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/B978-0-444-63437-5.00005-4","article-title":"The epidemiology of dizziness and vertigo","volume":"137","author":"Neuhauser","year":"2016","journal-title":"Handb. Clin. Neurol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1177\/014556131509401206","article-title":"Sensorineural hearing loss in \u03b2-thalassemia patients treated with iron chelation","volume":"94","author":"Osma","year":"2015","journal-title":"Ear, Nose Throat J."},{"key":"B44","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s40264-012-0014-6","article-title":"WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems","volume":"36","author":"Pal","year":"2013","journal-title":"Drug Saf."},{"key":"B45","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/0976-500X.120955","article-title":"Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two \u201cchallenging\u201d case reports","volume":"4","author":"Palleria","year":"2013","journal-title":"J. Pharmacol. Pharmacother."},{"key":"B46","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ijtb.2016.01.031","article-title":"Frequency of adverse events observed with second-line drugs among patients treated for multidrug-resistant tuberculosis","volume":"63","author":"Prasad","year":"2016","journal-title":"Indian J. Tuberc."},{"key":"B47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5772\/intechopen.79986","article-title":"Evolving roles of spontaneous reporting systems to assess and monitor drug safety","volume-title":"Pharmacovigilance","author":"Raschi","year":"2019"},{"key":"B48","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1002\/1097-0142(19900701)66:1<130::aid-cncr2820660123>3.0.co;2-p","article-title":"Etoposide versus etoposide plus high-dose cisplatin in the management of advanced non\u2013small cell lung cancer: results of a prospective randomized FONICAP trial","volume":"66","author":"Rosso","year":"1990","journal-title":"Cancer"},{"key":"B49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/pds.4125","article-title":"Differences in VigiBase\u00ae reporting of aminoglycoside and capreomycin-suspected ototoxicity during tuberculosis treatment","volume":"26","author":"Sagwa","year":"2017","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"B50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000088850","article-title":"Sketches of otohistory: part 11: ototoxicity: drug-induced hearing loss","volume":"11","author":"Schacht","year":"2006","journal-title":"Audiol. Neurotol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.anl.2016.10.005","article-title":"Clinical predictors of aminoglycoside-induced ototoxicity in drug-resistant tuberculosis patients on intensive therapy","volume":"44","author":"Sogebi","year":"2017","journal-title":"Auris Nasus Larynx"},{"key":"B52","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.det.2015.03.004","article-title":"Rheumatoid nodules","volume":"33","author":"Tilstra","year":"2015","journal-title":"Dermatol. Clin."},{"key":"B53","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.bjorl.2016.08.012","article-title":"Significant association between osteoporosis and hearing loss: a systematic review and meta-analysis","volume":"83","author":"Upala","year":"2017","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"B54","unstructured":""},{"key":"B55","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s002320001067","article-title":"K+ secretion in strial marginal cells is stimulated via\u03b21-adrenergic receptors but not via\u03b22-adrenergic or vasopressin receptors","volume":"175","author":"Wangemann","year":"2000","journal-title":"J. Membr. Biol."},{"key":"B56","unstructured":""},{"key":"B57","first-page":"24","article-title":"Tinnitus prevalence in New Zealand","volume":"128","author":"Wu","year":"2015","journal-title":"N. Z. Med. J."},{"key":"B58","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1517\/14740338.5.3.383","article-title":"Understanding drug ototoxicity: molecular insights for prevention and clinical management","volume":"5","author":"Yorgason","year":"2006","journal-title":"Expert Opin. Drug Saf."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01161\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T05:30:05Z","timestamp":1664602205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fphar.2019.01161\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,8]]},"references-count":58,"alternative-id":["10.3389\/fphar.2019.01161"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2019.01161","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,8]]},"article-number":"1161"}}